admin – Page 6734 – Get News Story

New Book “Behind the Red Line: Horrors of an or You’d Rather Never Know” Reveals Gripping Tale of Courage and Justice in the Healthcare Industry

Renowned authors V.V. Liles and Autumn Jade Monroe have unveiled their latest literary masterpiece, “Behind The Red Line: Horrors of an OR You’d Rather Never Know.” Set against the backdrop of the prestigious Heart Institute, this thrilling fictionalized account sheds light on the dark underbelly of medical corruption and the relentless pursuit of justice.

In this gripping tale, readers are introduced to Victoria Villa, the Director of Operations at a state-of-the-art Cardiology Institute, whose excitement for the grand opening rapidly turns into a nightmare. With the arrival of a touted ‘world-renowned’ cardiac surgeon, Dr. Shetan Pathan, Victoria finds herself plunged into a web of unethical behavior, manipulation, and greed that threatens not only her career but also the lives of unsuspecting patients.

As Victoria navigates through the treacherous waters of corruption, she finds herself facing personal tragedies and unforeseen challenges. Diagnosed with stage 4 cancer and reeling from the unexpected death of her beloved husband, Victoria’s resilience and determination are put to the ultimate test as she tirelessly pursues justice for those who have suffered at the hands of Dr. Pathan.

“Behind The Red Line: Horrors of an OR You’d Rather Never Know” is more than just a thrilling page-turner; it’s a powerful exploration of the human spirit and the quest for truth and morality in the face of adversity. Through Victoria’s journey, readers are inspired to confront corruption, advocate for change, and find hope amidst the darkest of times.

V.V. Liles, a first-time author with over 30 years of experience in the healthcare industry, brings a wealth of knowledge and insight to this compelling narrative. Co-author Autumn Jade Monroe’s talent for storytelling and her passion for justice shines through on every page, captivating readers from start to finish.

“Behind The Red Line: Horrors of an OR You’d Rather Never Know” is available for purchase on major book retailers and online platforms such as https://www.amazon.com/dp/1917238924/. For those seeking a riveting read that challenges the status quo and ignites the flames of resilience and justice, This book promises to deliver an unforgettable experience.

About the Author

V.V. Liles is a first-time author. Over the past 30 years, she has built a successful career in the Healthcare industry, primarily focusing in Clinical Leadership. She recently lost her husband of 28 years, but still lives with her 2 sons and new puppy in the home they built together.

Book Name: Behind the Red Line: Horrors of an OR You’d Rather Never Know

Author Name: V. V. Liles

ISBN Number: 978-1917238922

Ebook Version: Click Here

Paperback Version: Click Here

Media Contact
Company Name: Amazon Book Publication
Email: Send Email
Phone: +1-859-592-4410
Country: United States
Website: https://amzbookpublication.com/

Trailblazing AI Driven Early Cancer Diagnostics and Therapeutics for Detection with Nvidia Super Computing Power; Acquiring 100% Ownership of Cyclomics; Renovaro Inc. (Nasdaq: RENB)

$RENB is Working with $NVDA and Oxford Nanopore for Sequencing Technology and Front Edge Software Solutions

Renovaro Inc (Nasdaq: RENB) aims to accelerate precision and personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better-targeted treatments, and drug discovery. Renovaro includes Renovaro Bio with its advanced cell-gene immunotherapy company and RenovaroCube. RenovaroCube has developed an award-winning AI platform that is committed to the early detection of cancer and its recurrence and monitoring subsequent treatments. RenovaroCube intervenes at a stage where potential therapy can be most effective. RenovaroCube is a molecular data science company with a background in FinTech and a 10-year history. It brings together proprietary artificial intelligence (AI) technology, multi-omics, multi-modal data, and the expertise of a carefully selected multidisciplinary team to radically accelerate precision medicine and enable breakthrough changes in cancer care.

Upon the closing of the acquisition of Cyclomics (winner of the Health Holland Venture Challenge), RenovaroCube will be capable of performing liquid biopsies using proprietary technologies to identify single cancer DNA molecules in only one vial of blood. In combination with Oxford Nanopore Technology, genetic information can be retrieved over multiple genetic layers to develop the next generation of cancer diagnostics. This has the potential to transform cancer care by enabling faster and more accurate diagnosis throughout the patient journey.

RENB announces a significant milestone in their collaboration. RenovaroCube has entered into an amendment to its binding letter of intent to acquire 100% ownership of Cyclomics, further cementing their shared commitment to advancing state-of-the-art technologies in cancer diagnostics and treatment. Their combined relationships with Oxford Nanopore and Nvidia will further position RenovaroCube to be a leader in early cancer diagnostics and monitoring of treatment efficacy. Oxford Nanopore is a leader in sequencing technologies and Nvidia will provide vital supercomputing power and front-edge software solutions such as Parabricks, BioNeMo, Monai, and Nemo.

Initially set at a 75% acquisition, this decision to acquire the remaining 25% of Cyclomics reflects the resounding success of their partnership and the remarkable synergy between the two companies. Upon closing, we believe the acquisition of Cyclomics into the Renovaro family will further strengthen our ability to create a powerhouse for cancer diagnostics throughout the entire patient journey, from early detection/recurrence and personalized treatment in late-stage disease.

RENBs Combined Companies aim to Disrupt Cancer Diagnosis and treatment through early disease and recurrence detection, prediction of response to treatment, and personalized therapy.

DISCLAIMER: https://corporateads.com/disclaimer/

All Disclosures listed on the www.corporateads.com

Media Contact
Company Name: Renovaro Biosciences Inc
Contact Person: The Hon. Mark Dybul, MD, CEO
Email: Send Email
Phone: 732-780-5036
Address:2080 Century Park East Suite 906
City: Los Angeles
State: California 90067
Country: United States
Website: https://www.enochianbio.com/overview/default.aspx

BSA Claims Solutions: Setting the Standard for Customer Service Excellence in the Independent Insurance Adjuster Sector in Fort Lauderdale

Fort Lauderdale, FL – BSA Claims Solutions, a pioneering independent insurance adjuster company, is redefining industry standards with its unparalleled commitment to customer service excellence. With a strategic base in Fort Lauderdale, the company leverages local expertise and a comprehensive understanding of the community’s needs to deliver services beyond expectations.

In an industry where precision and reliability are paramount, BSA Claims Solutions stands out for its dedication to providing swift, accurate, and empathetic service to all its clients. “Our mission is to ensure that every client feels heard, valued, and thoroughly supported through every step of the claims process,” said Kim Porterfield, spokesperson for BSA Claims Solutions. “We believe that our focus on customer satisfaction is not just good practice; it’s a cornerstone of our business model.”

The company’s commitment to excellence is evident in its rigorous adjuster training programs, which emphasize the technical aspects of claims adjustment and the importance of customer care. This dual focus ensures that BSA Claims Solutions can handle claims efficiently while also addressing its clients’ emotional and practical needs.

BSA Claims Solutions’ approach is particularly impactful in Fort Lauderdale, a vibrant city known for its dynamic business environment and diverse community. By understanding the specific challenges and opportunities present in the local area, BSA Claims Solutions tailors its services to meet and exceed the unique needs of Fort Lauderdale residents and businesses.

The company’s expertise is wider than traditional claims adjustment. They are also at the forefront of utilizing cutting-edge technology to streamline the claims process, making it faster and more convenient for their clients. This innovative approach has not only enhanced the efficiency of their operations but has also significantly improved the overall customer experience.

In recognition of their exceptional service, BSA Claims Solutions has received numerous accolades from industry associations, local businesses, and, most importantly, their clients. These endorsements underscore the company’s position as a leader in the independent insurance adjuster field and a trusted partner to the Fort Lauderdale community.

As BSA Claims Solutions continues to grow and expand its services, the company remains steadfast in its commitment to customer service excellence. “Our goal is to set a new benchmark for what clients can expect from an independent insurance adjuster company,” Porterfield added. “We’re not just processing claims; we’re building lasting relationships based on trust, respect, and a shared commitment to excellence.”

About BSA Claims Solutions

BSA Claims Solutions is a leading independent insurance adjuster specializing in comprehensive claims adjustment services. With a focus on customer service excellence, BSA Claims Solutions offers a unique combination of local expertise and global resources to deliver outstanding client results.

For more information, please contact Kim Porterfield at https://www.bsaclaims.com/.

Media Contact
Company Name: BSA Claims Solutions
Contact Person: Kim Porterfield
Email: Send Email
Phone: +1 877-761-2332
Address:7800 Belfort Pkwy Suite 280
City: Jacksonville
State: FL
Country: United States
Website: https://www.bsaclaims.com/

Transforming Lives: Dr. Yamilette Lopez Leading the Way in Chiropractic Care, Jacksonville, FL

Dr. Yamilette Lopez with Vitality Family Chiropractic and Wellness Center empowers health and wellness through personalized Chiropractic care and expertise.

Meet Dr. Yamilette Lopez, also known as Dr. Yamy, the visionary force behind Vitality Family Chiropractic and Wellness Center in Jacksonville, FL. With a steadfast commitment to enhancing the well-being of her community, Dr.Lopez delivers top-tier chiropractic care and healthcare solutions to individuals throughout Jacksonville and its neighboring regions. Beyond her role as a skilled chiropractor in Jacksonville Fl, Dr. Lopez is a certified doula, bringing invaluable expertise to prenatal care. Her proficiency in the Webster Technique underscores her dedication to supporting expectant mothers on their journey to motherhood. Through her holistic approach and unwavering passion for healing, Dr. Lopez is revolutionizing healthcare in Jacksonville, one patient at a time.

At Vitality Family Chiropractic and Wellness Center, the ethos is centered around family-oriented care and specialized training to cater to diverse patient needs. Their overarching mission is to foster health and well-being by addressing the complete spectrum of patient health – structurally, nutritionally, and energetically. Dr. Yamy stands at the forefront of this mission, wielding expertise in a multitude of hands-on chiropractic techniques. From alleviating auto injuries to managing chronic conditions like arthritis, Dr. Yamy’s proficiency extends to a comprehensive range of ailments, including lower back, neck, shoulder, muscle, sciatic, and poor posture. She embraces the chiropractic philosophy that centers on influencing and enhancing the proper function of the body’s nervous system, thereby unlocking its innate capacity for self-healing. Through her compassionate care and dedication to holistic wellness, Dr. Yamilette Lopez and her team are transforming lives, one adjustment at a time.

According to Dr. Lopez, Chiropractic care offers a multitude of benefits that extend far beyond mere pain relief. By addressing the root cause of discomfort and dysfunction in the musculoskeletal system, chiropractic adjustments promote overall wellness and improved quality of life. One of the critical advantages of chiropractic care is its non-invasive nature, providing patients with a safe and drug-free alternative to conventional medical treatments.

“I am honored to lead the forefront of Chiropractic Care in Jacksonville FL, offering individualized care services in prenatal, postpartum, pediatric chiropractic, personal injury, auto accidents, and beyond,” says Dr. Yamilette Lopez.

Vitality Family Chiropractic offers a comprehensive range of services designed to address various health concerns and promote overall wellness. Their team comprises highly skilled and compassionate professionals dedicated to providing exceptional care to every patient. With a commitment to ongoing education and staying abreast of the latest advancements in chiropractic care, Vitality Family Chiropractic staff ensures that patients receive the highest treatment and support on their journey to optimal health and vitality.

Patient Testimonials:

“Excellent service. I had problems in my neck and a lot of pain, and with decompression therapy, they fixed it… Dr. Lopez and all the staff are very helpful. Highly recommended.”

“I was skeptical about seeing a chiropractor for the longest time, which caused more pain as I waited, but once I came across this Health center, I was amazed at how excellent and caring the staff is. They genuinely try to promote good health habits and care about their patients’ well-being.”

For individuals in Jacksonville, FL, seeking immediate relief or ongoing chiropractic care, Vitality Family Chiropractic stands as a beacon of expertise and accessibility. Their commitment to providing quality chiropractic services extends to offering walk-in appointments and same-day consultations. With a dedicated team of professionals and a comprehensive range of services, including prenatal and pediatric chiropractic care, patients can trust to receive personalized treatment tailored to their specific needs.

For more information on Vitality Family Chiropractic and Wellness Center or to schedule a same-day chiropractic care appointment, visit their website or visit their location and speak to a professional staff member.

Media Contact
Company Name: Vitality Family Chiropractic and Wellness Center
Contact Person: Dr. Yamilette Lopez
Email: Send Email
Country: United States
Website: https://vitalitycenterjax.com/

The Bespoke Dentist Leads the Way in Safe Amalgam Removal in London and Beyond (Europe, Asia, Middle East, Dubai/Abu Dhabi)

The Bespoke Dentist stands at the forefront of safe and responsible removal practices.

As concerns rise regarding mercury in traditional amalgam fillings, The Bespoke Dentist stands at the forefront of safe and responsible removal practices. Led by Dr. Daniel Sutcliffe, the clinic is one of the few UK practices IAOMT certified in this service. Dr. Sutcliffe’s expertise, coupled with the clinic’s meticulous safety protocols and unwavering commitment to patient-centered care, attracts a global clientele seeking a solution that prioritises their well-being. Patients from Europe, Asia, the Middle East, and regions like Dubai and Abu Dhabi entrust The Bespoke Dentist with this crucial procedure.

“Amalgam fillings, while common, contain mercury, a known neurotoxin that can potentially affect health over time,” explains Dr. Sutcliffe. “Our practice recognises the need for safe and responsible removal of these fillings to minimise risk. We take cautious steps to protect our patients, staff, and the environment by strictly adhering to the IAOMT protocols for safe amalgam removal established by leading dental organisations.”

To ensure the safest possible experience, The Bespoke Dentist follows a delicate process for safe amalgam removal in London and beyond. This includes using equipment to filter the air and reduce potential mercury exposure for patients and staff. Patients are provided with protective gear, and alternative breathing sources are used during the procedure. The clinic employs advanced technologies to capture and dispose of any mercury released during the removal, ensuring environmental responsibility. Furthermore, the clinic provides comprehensive guidance and support after the procedure, assisting patients with detoxification processes for optimal health and well-being.

While traditional filling removal may appear straightforward, safe amalgam removal requires knowledge and IAOMT precautions that only a highly skilled amalgam removal dentist like Dr. Sutcliffe possesses. The unique complexities of mercury-containing fillings demand advanced techniques and technologies to prioritise patient health and environmental safety. Dr. Sutcliffe’s expertise and The Bespoke Dentist’s commitment to rigorous protocols ensure a comfortable and risk-free experience. Patients seeking amalgam removal can trust the clinic to deliver exceptional care and prioritise their well-being.

The Bespoke Dentist distinguishes itself with a patient-centered philosophy that goes beyond exceptional dental care. The clinic understands the potential anxieties associated with dental procedures, particularly those involving treatments like amalgam removal. This is why they offer a warm and reassuring environment where open communication and individualised care are paramount. Patients are empowered through knowledge and supported every step of the way, ensuring a seamless and positive experience from consultation to recovery.

To learn more about The Bespoke Dentist’s commitment to safe amalgam removal and comprehensive dental care, visit their website at https://thebespokedentist.co.uk/

Media Contact
Company Name: The Bespoke Dentist
Contact Person: Dr. Daniel Sutcliffe
Email: Send Email
Phone: +44 20 7099 6651
Address:28 Harley Pl
City: London
Country: United Kingdom
Website: https://thebespokedentist.co.uk/

WheelHouse IT Champions Sustainability in IT Consulting Practices in Fort Lauderdale

WheelHouse IT, a leading provider of IT consulting services, is proud to announce its renewed commitment to sustainability within the tech industry.

Fort Lauderdale, FL – WheelHouse IT, a leading provider of IT consulting services, is proud to announce its renewed commitment to sustainability within the tech industry. This initiative reflects the company’s dedication to combining innovative IT solutions with environmentally responsible practices, setting a new standard for businesses in Fort Lauderdale and beyond.

In an era where technology and sustainability intersect, WheelHouse IT stands at the forefront, integrating green practices into its IT consulting services. “Our commitment to sustainability is not just about reducing our carbon footprint,” says Gani Zebersky, spokesperson for WheelHouse IT. “It’s about leading by example and helping our clients implement IT solutions that are efficient, reliable, and environmentally friendly.”

WheelHouse IT’s sustainability strategy encompasses a comprehensive approach, including promoting energy-efficient data centers, recycling electronic waste, and advising clients on sustainable IT practices. By prioritizing these initiatives, WheelHouse IT aims to contribute to a more sustainable future, emphasizing the importance of environmental responsibility in the rapidly evolving tech landscape.

A Sustainable Approach to IT Consulting

WheelHouse IT’s commitment to green IT practices is evident in its consultancy services. The firm advises businesses on adopting sustainable technologies and practices that reduce energy consumption and minimize waste. This approach helps companies align with environmental goals and leads to cost savings and improved operational efficiency.

Educating the Community

Beyond their consultancy services, WheelHouse IT is dedicated to raising awareness about the importance of sustainability in the tech industry. Through workshops, seminars, and community events, the company educates businesses and individuals in Fort Lauderdale and beyond about the benefits of sustainable IT practices.

About WheelHouse IT

WheelHouse IT is a leading provider of comprehensive IT consulting services, offering innovative and sustainable technology solutions to businesses in Fort Lauderdale and nationwide. With a commitment to excellence and a focus on sustainable practices, WheelHouse IT empowers companies to achieve their goals while contributing to a healthier planet.

For more information, please contact Gani Zebersky at +1 877-771-2384, email sales@wheelhouseit.com, or visit WheelHouse IT’s website at https://www.wheelhouseit.com/.

Media Contact
Company Name: WheelHouse IT
Contact Person: Gani Zebersky
Email: Send Email
Phone: +1 877-771-2384
Address:2890 Marina Mile Blvd, 108 W State Rd. 84 Suite
City: Fort Lauderdale
State: FL
Country: United States
Website: https://www.wheelhouseit.com

Nonalcoholic Steatohepatitis Market to Observe Impressive Growth During the Forecast Period | Inventiva Pharma, Zydus Therapeutics, Novo Nordisk A/S, Eli Lilly and Company, Madrigal Pharmaceuticals

“Nonalcoholic Steatohepatitis Market”

DelveInsight’s “Nonalcoholic Steatohepatitis (NASH) Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Nonalcoholic Steatohepatitis (NASH), historical and forecasted epidemiology as well as the Nonalcoholic Steatohepatitis (NASH) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Nonalcoholic Steatohepatitis (NASH) Market is poised for growth in the upcoming years, driven by the rising incidence of NASH in the 7MM (Seven Major Markets) and the forthcoming introduction of innovative therapies.

Global companies are actively engaged in the development of novel treatment modalities, achieving significant progress over time. Among the prominent contributors to drug development for Non-Alcoholic Steatohepatitis are Inventiva Pharma, Novo Nordisk, Intercept Pharmaceuticals, Madrigal Pharmaceuticals, Inc., and others.

The current pipeline of NASH consists of plenty of drugs. FXR Agonists, FGF21 Stimulants, FGF19 Analog, Glucagon-like Peptide-1 (GLP-1) Agonist, Peroxisome Proliferator-activated Receptor (PPAR) Regulators, THR-β Agonist, and some others are the most highlighted class of this indication. Ongoing research and current trials can potentially change the Nonalcoholic Steatohepatitis (NASH) treatment scenario in the coming years.

DelveInsight’s “Nonalcoholic Steatohepatitis (NASH) Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Nonalcoholic Steatohepatitis (NASH) market size, share, trends, and growth opportunities in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).

The Nonalcoholic Steatohepatitis (NASH) market report covers emerging drugs, current treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.

Nonalcoholic Steatohepatitis (NASH) Overview

Non-alcoholic fatty liver disease (NAFLD) serves as a comprehensive term encompassing the entire spectrum of fatty liver conditions, ranging from simple steatosis to more advanced stages involving hepatitis, fibrosis, cirrhosis, and, in severe instances, hepatocellular carcinoma.

Within the NAFLD spectrum, Nonalcoholic Steatohepatitis (NASH) represents the progressive form of liver injury, posing risks of advancing fibrosis, cirrhosis, and eventual liver failure. This prevalent chronic liver ailment is characterized by liver inflammation and damage induced by fat accumulation. Children, under certain unhealthy conditions, may also develop NAFLD and NASH, mirroring occurrences in adults. The precise reasons behind why some children with NAFLD develop simple fatty liver while others progress to NASH remain unclear.

Treatment for NASH lacks a standardized approach; however, lifestyle modifications have demonstrated efficacy in influencing disease progression. These lifestyle adjustments may entail weight loss, adhering to a balanced diet, and managing underlying health conditions such as hypothyroidism and diabetes. In cases where NASH coexists with cirrhosis, treatment may involve medications and potentially surgical interventions. Individuals with NASH complications, such as liver cancer or liver failure, may necessitate liver transplantation.

Nonalcoholic Steatohepatitis (NASH) Market Key Facts

In the US, there were approximately 20 million prevalent cases of NASH in 2021, which is anticipated to rise by 2032.
In 2021, 57% of males and around 43% of females were found to be affected by NASH in the US.
According to a study by Petta et al. (2019), NAFLD is one of the most frequent causes of chronic liver disease worldwide, affecting around 24% of the global population. In Italy, NAFLD prevalence ranges between 20%-30%. Nonalcoholic steatohepatitis (NASH) comprises nearly 25% of NAFLD patients.
Park et al. (2021), in their study, found that the overall prevalence of NAFLD was 31.46%. NASH prevalence was 52%, but <15% had significant fibrosis.
It is observed that males are slightly more likely to get affected by NASH than females in the 7MM.
On January 20, 2023, Intercept Pharmaceuticals, Inc. announced that the FDA had accepted the company’s new drug application (NDA) for obeticholic acid (OCA) that seeks accelerated approval for the treatment of patients with pre-cirrhotic liver fibrosis due to nonalcoholic steatohepatitis (NASH).
On January 4, 2023, SFA Therapeutics announced that it had received clearance for its Investigational New Drug (IND) application from the U.S. Food and Drug Administration (FDA) to investigate SFA-001N in patients with non-alcoholic steatohepatitis (NASH) with or without fibrosis. SFA-001N is designed to act on multiple pathways involved in the pathogenesis of NASH.
On December 08, 2022, Akero Therapeutics, Inc. (Nasdaq: AKRO) announced that efruxifermin (EFX) had received a Breakthrough Therapy Designation from the US Food and Drug Administration (FDA) for the treatment of nonalcoholic steatohepatitis (NASH).
On May 26, 2022, Pfizer Inc. (NYSE: PFE) announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Pfizer’s investigational combination therapy for the treatment of non-alcoholic steatohepatitis (NASH) with liver fibrosis: ervogastat (PF-06865571, a diacylglycerol O-acyltransferase 2 inhibitor, or DGAT2i) and clesacostat (PF-05221304, an acetyl-CoA carboxylase inhibitor, or ACCi).

Nonalcoholic Steatohepatitis (NASH) Market

The market outlook section of the report helps to build a detailed comprehension of the historical, current and forecasted Nonalcoholic Steatohepatitis (NASH) market size by analyzing the impact of current and emerging pipeline therapies. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies set to impact the market dynamics.

The report gives complete detail of the Nonalcoholic Steatohepatitis (NASH) market trend for each marketed drug and mid & late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, their Mechanism of Action (MOA), Route of Administration (ROA), molecule types, competition with other therapies, brand value, and their impact on the market.

Nonalcoholic Steatohepatitis (NASH) Epidemiology Assessment

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted epidemiology trends by exploring numerous studies and research. The epidemiology section also provides a detailed analysis of diagnosed and prevalent patient pool, future trends, and views of key opinion leaders.

Report Covers the Nonalcoholic Steatohepatitis (NASH) Epidemiology, Segmented by –

Gender-specific Diagnosed Prevalent Cases of Non-Alcoholic Steatohepatitis (NASH) in the 7MM (2019-32)
Total Diagnosed Prevalent Cases of Non-Alcoholic Steatohepatitis (NASH) in the 7MM (2019-32)
Total Prevalent Cases of Non-Alcoholic Steatohepatitis (NASH) in the 7MM (2019-32)
Severity-specific Diagnosed Prevalent Cases of Non-Alcoholic Steatohepatitis (NASH) (F0, F1, F2, F3, and F4 (Cirrhosis)) in the 7MM [2019–2032]
Treatable Cases of Non-Alcoholic Steatohepatitis (NASH) in the 7MM (2019-32)

Nonalcoholic Steatohepatitis (NASH) Drugs Uptake and Pipeline Development Activities

The drug uptake section focuses on the rate of uptake of the potential drugs recently launched in the Nonalcoholic Steatohepatitis (NASH) market or expected to be launched during the study period. The analysis covers the Nonalcoholic Steatohepatitis (NASH) market uptake by drugs, patient uptake by therapies, and sales of each drug. Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Nonalcoholic Steatohepatitis (NASH) pipeline development activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Learn How the Nonalcoholic Steatohepatitis (NASH) Market Will Evolve and Grow by 2032 @ https://www.delveinsight.com/sample-request/nonalcoholic-steatohepatitis-nash-market

Nonalcoholic Steatohepatitis (NASH) Therapeutics Analysis

At present, no medications have received approval from the FDA, EMA, or PMDA (Pharmaceuticals and Medical Devices Agency) specifically for treating NASH. However, ongoing research is exploring potential drugs to address this condition. The primary approach to managing NASH currently involves lifestyle adjustments, including dietary changes and physical activity. In addition to these modifications, other treatment possibilities for NASH encompass the off-label utilization of vitamin E and anti-diabetic medications such as pioglitazone and liraglutide. Numerous prominent companies are actively engaged in advancing treatments within the Nonalcoholic Steatohepatitis (NASH) Therapeutics Market to enhance treatment options.

Madrigal Pharmaceuticals currently leads the therapeutics market, advancing Nonalcoholic Steatohepatitis drug candidates in the most advanced stages of clinical development.

The Leading Pharma and Biotech Companies in the Nonalcoholic Steatohepatitis (NASH) Therapeutics Market Include:

Madrigal Pharmaceuticals, Cirius Therapeutics, AstraZeneca, Ionis Pharmaceuticals, NorthSea Therapeutics, Rivus Pharmaceuticals, Akero Therapeutics, Merck Sharp & Dohme LLC, Enanta Pharmaceuticals, TaiwanJ Pharmaceuticals, Cascade Pharmaceuticals, Hepion Pharmaceuticals, Chipscreen Biosciences, Boston Pharmaceuticals, Bristol-Myers Squibb, GSK plc., Amgen, Altimmune, Inc., Sciwind Biosciences, SCOHIA PHARMA, Galecto Biotech, J2H Biotech, Tiziana Life Sciences, Palobiofarma, Bird Rock Bio, Ascletis, Liminal BioSciences, ARTham Therapeutics, Pliant Therapeutics, Guangdong Zhongsheng Pharmaceutical, Pharmaxis, Melior Pharmaceuticals, TransThera Biosciences, Cerenis Therapeutics, DURECT Corporation, Enzychem Lifesciences, Ildong Pharmaceutical, LG Chem Life Sciences, Gmax Biopharm, Albireo Pharma, InorbitTX, Viking Therapeutics, Ildong Pharmaceutical, Thoth Science, and various others.

Nonalcoholic Steatohepatitis Therapies Covered in the Report Include:

Resmetirom: Madrigal Pharmaceuticals
ION224: Ionis Pharmaceuticals
MSDC-0602K: Cirius Therapeutics
HU 6: Rivus Pharmaceuticals
HTD 1801: HighTide Biopharma
EDP-305: Enanta Pharmaceuticals
Lanifibranor: Inventiva Pharma
Saroglitazar Magnesium: Zydus Therapeutics
Semaglutide: Novo Nordisk A/S
Tirzepatide: Eli Lilly and Company
MGL-3196 (Resmetirom): Madrigal Pharmaceuticals, Inc
TERN-501: Terns, Inc.
Obeticholic acid (OCA): Intercept Pharmaceuticals
Vonafexor (EYP001): Enyo Pharma
Pegozafermin: 89bio, Inc.
Efruxifermin (EFX): Akero Therapeutics, Inc
EA3571: EA Pharma
And Many More

Report Covers the In-depth Assessment of the Emerging Drugs & Key Companies. Download the Sample Report to Learn More @ https://www.delveinsight.com/sample-request/nonalcoholic-steatohepatitis-nash-market

Table of Contents

1. Key Insights

2. Executive Summary

3. Nonalcoholic Steatohepatitis (NASH) Competitive Intelligence Analysis

4. Nonalcoholic Steatohepatitis (NASH) Market Overview at a Glance

5. Nonalcoholic Steatohepatitis (NASH) Disease Background and Overview

6. Nonalcoholic Steatohepatitis (NASH) Patient Journey

7. Nonalcoholic Steatohepatitis (NASH) Epidemiology and Patient Population (In the US, EU5, and Japan)

8. Nonalcoholic Steatohepatitis (NASH) Treatment Algorithm, Current Treatment, and Medical Practices

9. Nonalcoholic Steatohepatitis (NASH) Unmet Needs

10. Key Endpoints of Nonalcoholic Steatohepatitis (NASH) Treatment

11. Nonalcoholic Steatohepatitis (NASH) Marketed Products

12. Nonalcoholic Steatohepatitis (NASH) Emerging Drugs and Latest Therapeutic Advances

13. Nonalcoholic Steatohepatitis (NASH) Seven Major Market Analysis

14. Attribute Analysis

15. Nonalcoholic Steatohepatitis (NASH) Market Outlook (In US, EU5, and Japan)

16. Nonalcoholic Steatohepatitis (NASH) Access and Reimbursement Overview

17. KOL Views on the Nonalcoholic Steatohepatitis (NASH) Market

18. Nonalcoholic Steatohepatitis (NASH) Market Drivers

19. Nonalcoholic Steatohepatitis (NASH) Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

Download the Sample PDF to Learn More About the Key Offerings of the Report @ https://www.delveinsight.com/sample-request/nonalcoholic-steatohepatitis-nash-market

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Nonalcoholic Steatohepatitis Market to Observe Impressive Growth During the Forecast Period | Inventiva Pharma, Zydus Therapeutics, Novo Nordisk A/S, Eli Lilly and Company, Madrigal Pharmaceuticals

Vello Revolutionizes the Short-Term Rental Scene in Major US Cities with Innovative Management Solutions

Vello is shaking up the short-term rental market in major US cities, offering a revolutionary approach that streamlines management and maximizes returns for property owners.

Vello is shaking up the short-term rental market in major US cities, offering a revolutionary approach that streamlines management and maximizes returns for property owners. Their advanced technology platform simplifies the complexities of short-term rentals, while expert support that includes interior design advice, professional photography, and ongoing market analysis, guarantees maximum profitability. This innovative model is attracting widespread attention and driving Vello’s expansion into key short-term rental hotspots across the country.

“We understand the pain points faced by short-term rental owners,” said William Myers of Vello. “Our mission is to empower anyone to succeed in this market, regardless of their experience level. Vello’s technology and expert team provide a seamless solution, allowing owners to focus on the rewards of their investment without the time-consuming burdens.”

The booming popularity of Airbnb in Tampa, FL, and in major US cities has created immense opportunities for property owners. However, navigating this dynamic market can be complex, which is where an experienced Airbnb property management company in Tampa, like Vello, can provide a distinct advantage. Vello’s comprehensive solutions help owners maximize the potential of their Airbnb listings, attracting more guests, and ultimately achieving superior returns on their investment.

While the potential rewards of Airbnb rentals are undeniable, managing such properties can be a significant undertaking. Without a short-term vacation rental property management company like Vello, owners risk encountering a multitude of challenges. These can include difficulties with guest communication, maintaining a consistent cleaning schedule, and ensuring optimal pricing strategies – all factors that directly impact a property’s profitability and guest satisfaction. Vello’s expertise tackles these hurdles head-on, allowing owners to enjoy the benefits of short-term rentals without the burden of day-to-day operations.

Vello understands that the short-term rental market is constantly evolving. Their approach combines adaptable technology with proactive market analysis, ensuring that listings remain competitive and profitable. From adjusting pricing strategies in response to changing demand to providing owners with up-to-the-minute local regulations, Vello keeps properties one step ahead. This focus on agility sets them apart, demonstrating their commitment to helping owners thrive in a dynamic environment.

Ready to optimize short-term rental earnings? Visit Vello’s website at https://stayvello.com/ to see how its advanced solutions can streamline operations and maximize returns. Discover case studies, explore features, and learn how to unlock a property’s full potential.

Media Contact
Company Name: Vello Property Management
Contact Person: Will Meyers
Email: Send Email
Phone: (504) 512-8651
Address:1626 Gentilly Blvd.
City: New Orleans
State: LA
Country: United States
Website: https://stayvello.com/

Introducing “The Boomer Effect”: A Podcast Bridging Generational Divides

Exploring generation perspectives and fostering connections across generations.

Generational differences and societal shifts are at the forefront of public discourse, shaping perceptions, attitudes, and interactions across diverse demographics. The Boomer Effect Podcast aims to offer a nuanced exploration of these different perspectives and bridge the divide between generations.

Hosted by industry luminaries Jerry Smith, the founder of JLS Sales Academy, and Rose Tennent, host of Rose Unplugged, The Boomer Effect delves into the experiences and identities of each generation while uncovering common ground and shared values. This offers insights into the trajectory of societal progress and the shaping of collective identities.

The Boomer Effect Podcast boasts an impressive lineup of guests from diverse backgrounds, offering a multifaceted exploration of generational perspectives. From thought leaders and political figures to artists, authors, and entrepreneurs, the podcast features a wide range of voices that contribute to its dynamic and engaging dialogue. Each episode offers actionable takeaways, empowering individuals to navigate the complexities of generational dynamics with empathy and understanding.

The episodes explore the impact of historical events, dissect societal norms, and discuss the changing dynamics of family structures and workplace environments. By tracing the events and movements that have defined each generation, The Boomer Effect Podcast offers a panoramic view of how societal norms and values evolve. This enables listeners to contextualize their own experiences within the broader landscape of generational history, fostering a deeper sense of connection and continuity across age groups.

The Boomer Effect Podcast not only celebrates the wisdom and experiences of older generations but also empowers younger listeners to navigate their unique journey with purpose. Through thoughtful conversations and shared narratives, the podcast promotes intergenerational solidarity and paves the way for meaningful collaborations.

Whether one’s a Baby Boomer reflecting on legacy, a Millennial charting career path, or a Gen Z shaping the future, The Boomer Effect embraces the collective wisdom of the past, present, and future to build bridges across generations and create a positive change in communities and beyond.

“Every generation brings unique experiences and viewpoints to the table. Join us as we explore the diverse perspectives of Baby Boomers, Gen X, Millennials, and Gen Z on The Boomer Effect Podcast,” says Smith.

With its commitment to fostering empathy and connection, The Boomer Effect Podcast aims to leave a lasting impact on its listeners, encouraging them to approach generational differences with curiosity, respect, and an open mind.

The Boomer Effect is available on Spotify, Apple Podcast, and Rumble. For more information, please visit http://theboomereffect.com.

Media Contact
Company Name: The Boomer Effect
Contact Person: Jerry Smith
Email: Send Email
Country: United States
Website: http://theboomereffect.com/

Jeff Turnbow, AI Expert, Earns MIT Certification, Enabling Him to Leverage AI to Help Clients Transform Operations

Jeff Turnbow, AI business consultant, AI expert, AI speaker trainer and sales and marketing strategist.

Veteran business consultant stresses the need for innovative technologies to compete in today’s market

CONWAY, Ark. – April 25, 2024 – Jeff Turnbow, the AI business consultant, AI expert, AI speaker trainer and sales and marketing strategist, today announced that he has completed MIT Sloan certification program Artificial Intelligence: Implications for Business Strategy. With the skills and knowledge Turnbow has acquired through the certification, he is now able to empower clients in the use of AI in strategy and marketing, as well as business efficiency.

“Generative AI is revolutionizing the way we do business,” said Turnbow, who is renowned as a digital marketing expert “I have used AI beginning in 2009 and have seen the importance of innovative technology. I decided to advance my knowledge and learn how AI can be more integrated into organizations to transform their operations and ongoing success.”

Jeff Turnbow

The MIT Sloan program hosted its intensive six-6-week comprehensive course, exploring the evolution of AI and how business strategy can utilize AI in marketing, innovation, and efficiency improvement. The unique certification includes resources from both MIT Sloan School of Management and the MIT Computer Science and Artificial Intelligence Laboratory. The program offered a comprehensive conceptual business understanding of AI technologies.

Turnbow was immersed in coursework modules including:

• Machine Learning in Business

• Natural Language Processes in Business

• Robotics in Business

• Artificial Intelligence (AI) in Business

• Generative AI in Business

• The Future of AI in Business

The program Turnbow completed required the development of an authentic working business strategy, ready for presentation for C-suite evaluation, with insights and strategies to adapt to and work with generative AI to drive ROI and profits.

The certification is unique in that it includes powerful perspectives from two MIT schools — the MIT Sloan School of Management and the MIT Computer Science and Artificial Intelligence Laboratory — offering a sound conceptual understanding of AI technologies through a business lens.

ABOUT JEFF TURNBOW

Jeff Turnbow is a 25-year experienced business consultant, business coach, trainer, sales and marketing strategist and global speaker.

For information visit https://www.jeffturnbow.com/ and https://winninglocal.com/

Media Contact
Company Name: Jeff Turnbow
Contact Person: Media Relations
Email: Send Email
Country: United States
Website: https://www.jeffturnbow.com/